MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ
1.690
-0.033
-1.90%
After Hours: 1.770 +0.08 +4.73% 16:36 12/04 EST
OPEN
1.730
PREV CLOSE
1.723
HIGH
1.770
LOW
1.690
VOLUME
31.38K
TURNOVER
--
52 WEEK HIGH
4.490
52 WEEK LOW
1.550
MARKET CAP
11.89M
P/E (TTM)
-1.2720
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 3d ago
Weekly Report: what happened at EDSA last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at EDSA last week (1117-1121)?
Weekly Report · 11/24 09:11
Weekly Report: what happened at EDSA last week (1110-1114)?
Weekly Report · 11/17 09:11
Weekly Report: what happened at EDSA last week (1103-1107)?
Weekly Report · 11/10 09:10
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 11/04 12:05
Edesa Biotech (EDSA) Receives a Buy from H.C. Wainwright
TipRanks · 11/03 16:35
Edesa Biotech Price Target Maintained With a $5.00/Share by HC Wainwright & Co.
Dow Jones · 11/03 16:11
More
About EDSA
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing ways to treat inflammatory and immune-related diseases. The Company’s clinical pipeline is focused on two therapeutic areas: medical dermatology and respiratory. In medical dermatology, the Company is developing EB06, an anti-CXCL10 monoclonal antibody candidate, as a therapy for vitiligo, a common autoimmune disorder that causes skin to lose its color in patches. Its medical dermatology assets also include EB01 (1.0% daniluromer cream), a Phase III-ready asset developed for use as a potential therapy for moderate-to-severe chronic allergic contact dermatitis (ACD), a common occupational skin condition. The Company’s advanced respiratory drug candidate is EB05 (paridiprubart), which is being evaluated in a United States government-funded platform study as a treatment for acute respiratory distress syndrome.

Webull offers Edesa Biotech Inc stock information, including NASDAQ: EDSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDSA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EDSA stock methods without spending real money on the virtual paper trading platform.